Navigation Links
Neurosurgeons from around the world gather at PLA 301 Hospital in China
Date:4/8/2009

WINNIPEG, April 8 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated in China's first international conference on intra-operative MR held at PLA 301 Hospital in Beijing on April 5, 2009. Over 300 neurosurgeons from China, USA, Germany, Taiwan and Hong Kong attended the inaugural event that focused on developments in intra-operative MR for neurosurgery. The conference was opened by Dir Chen Xiaohong, Director of PLA 301, and featured scientific presentations from Peter Black, Professor of Neurosurgery, Harvard Medical School, Christopher Nimsky, Professor and Chairman of Neurosurgery, University Marburg, and Michael Buchfelder, Professor and Chairman of Neurosurgery, University of Erlangen.

The conference program included the official opening of PLA 301's IMRISneuro suite - the first-of-its-kind surgical OR with integrated intra-operative MR imaging in China. Featuring a 1.5 Tesla wide bore magnet, IMRISneuro provides the hospital's surgical team with high quality images before, during and after procedures without moving the patient. Over 150 of the conference delegates were able to observe portions of a live case tumor resection using the new system.

PLA 301's neurosurgical team completed its first procedure on February 23, 2009, and completed five procedures in the first week of operation. In the six weeks since installation of the IMRISneuro suite, the team treated 43 patients suffering with glioma or epilepsy. While PLA 301 is widely-recognized for performing at the highest of global clinical standards, Dr. Xu Bainan, Chairman of Neurosurgery, said: "IMRIS has significantly advanced our neurosurgical capabilities and the system is contributing directly to our hospital's reputation as a world-class facility."

At the conference, David Graves, President and CEO of IMRIS shared his excitement about the project. "It is an honor to have been chosen by the neurosurgical team at PLA 301", said Mr. Graves. "We are certain this technology in their hands will help continue to provide the highest quality of care for their patients."

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers. For more information, visit www.imris.com.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
2. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
3. Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009
4. GTSI Forms Strategic Business Unit Around its Burgeoning Healthcare Solutions Practice
5. Alivemax -- A Company Releasing Supplemental Products That Will Uplift the Health, Appearance, and Confidence of Others Around the Globe
6. Precyse Solutions Adds Executives, Realigns Around Service Lines
7. PA DEP Finds Air Quality Around Schools to be Safe
8. Millions Around World to Observe Rare Disease Day
9. Univision Radio Stations Around the Country Support St. Jude Feb. 5 & 6
10. 20 MedSpa Professionals Gain Insight into MedSpa Business Turnaround Tactics
11. Borosage Urges Progressives to Rally Around Obama Economic Recovery Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: